Evaluating and monitoring liver disease severity in glycogen storage disease type IX: Performance of novel and established clinical scores. Genetics in Medicine Open. 2026; 4:103455.
Skeletal involvement in Erdheim-Chester disease: Multimodality imaging features and association with the BRAFV600E mutation. Clinical Imaging. 2024; 106:110067.
A retrospective longitudinal study and comprehensive review of adult patients with glycogen storage disease type III. Molecular Genetics and Metabolism Reports. 2021; 29:100821.
Physical therapy assessment and whole-body magnetic resonance imaging findings in children with glycogen storage disease type IIIa: A clinical study and review of the literature. Molecular Genetics and Metabolism. 2021; 134(3):223-234.
18Fluorodeoxyglucose-positron emission tomography/computed tomography for differentiation of renal tumors in hereditary kidney cancer syndromes. Abdominal Radiology. 2021; 46(7):3301-3308.
Hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome: Spectrum of imaging findings. Clinical Imaging. 2020; 68:14-19.
Thoracic involvement in Erdheim-Chester disease: computed tomography imaging findings and their association with the BRAFV600E mutation. European Radiology. 2018; 28(11):4635-4642.
Assessing lymph node status in patients with kidney cancer. Translational Andrology and Urology. 2018; 7(5):766-773.
Differentiating papillary type I RCC from clear cell RCC and oncocytoma: application of whole-lesion volumetric ADC measurement. Abdominal Radiology. 2018; 43(9):2424-2430.
Biological sex variation in bone mineral density in the cranium and femur. Science and Justice. 2018; 58(4):287-291.